Lower plasma ApoA1 levels are found in Parkinson’s disease and associate with APOA1 genotype

BACKGROUND: The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson’s disease (PD). Here we explore the role of plasma Apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promoter variation on plasma ApoA1 levels. ME...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mov Disord
Hlavní autoři: Swanson, Christine R., Li, Katherine, Unger, Travis L., Gallagher, Michael D., Van Deerlin, Vivianna M., Agarwal, Pinky, Leverenz, James, Roberts, John, Samii, Ali, Gross, Goldmann Rachel, Hurtig, Howard, Rick, Jacqueline, Weintraub, Daniel, Trojanowski, John Q., Zabetian, Cyrus, Chen-Plotkin, Alice S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362847/
https://ncbi.nlm.nih.gov/pubmed/25227208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26022
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky